Zymeworks Inc. (NASDAQ:ZYME) Q2 2023 Earnings Call August 10, 2023 4:30 PM ET

Company Participants

Diana Papove - Director of Corporate Communications

Chris Astle - Senior Vice President and Chief Financial Officer

Kenneth Galbraith - Chair and Chief Executive Officer

Paul Moore - Chief Scientific Officer

Conference Call Participants

Jon Miller - Evercore

Yigal Nochomovitz - Citigroup

Charles Zhu - Guggenheim

Brian Cheng - JP Morgan

Operator

Thank you for standing by. This is the conference operator. Welcome to Zymeworks Second Quarter 2023 Results Conference Call and Webcast. As a reminder, all participants are in a listen-only mode. And the conference is being recorded. After the presentation, there will be an opportunity to ask questions. [Operator Instructions]

I would now like to turn the conference over to Diana Papove, Director, Corporate Communications at Zymeworks. Diana, please go ahead.

Diana Papove

Good afternoon, and welcome, everyone. My name is Diana Papove, Director of Corporate Communications here at Zymeworks. Today, we will discuss our half year 2023 financial results, as well as provide an update on our ongoing business.

Before we begin, I would like to remind you that we will be making a number of forward-looking statements during this call, including without limitation those forward-looking statements identified in our presentation slides and the accompanying oral commentary.

Forward looking statements are based upon our current expectations and various assumptions and are subject to the usual risks and uncertainties associated with companies in our industry and at our stage of development. For a discussion of these risks and uncertainties, we refer you to our latest SEC filings as found on our website and as filed with the SEC.

In a moment, Chris Astle, our Senior Vice President and Chief Financial Officer, will be discussing our financial results, including certain non-GAAP measures, A description of our non-GAAP measures and a reconciliation to the most directly comparable financial measures as determined in accordance with GAAP are described in detail in our press release, which is available on our website at www.zymeworks.com under the Investor Relations tab. As a reminder, the audio and slides from this call will also be available on the Zymeworks website later today.

Now, I will turn the call over to Chris, our Senior Vice President and CFO.

Chris Astle

Thanks, Diana, and thank you everyone for joining us today for our second quarter 2023 earnings call.

I'll be presenting prepared remarks and participating in the Q&A today. Our Chair and Chief Executive Officer, Kenneth Galbraith; and our Chief Scientific Officer, Paul Moore, will also be available for Q&A at the end of the call.